IRF2BP2 and Abnormal intestine morphology: Regarding phenotype, patient 2.1, carrier of a de novo insertion (p.Ala110Argfs*48), suffered Crohn’s like enteropathy treated for a long time with anti-TNF therapy, and represents a good example of enteropathy associated with IRF2BP2-CVID.